Home » Stocks » PMD

Psychemedics Corporation (PMD)

Stock Price: $7.33 USD -0.06 (-0.81%)
Updated Jul 29, 2021 4:00 PM EDT - Market closed
After-hours: $7.00 -0.33 (-4.50%) Jul 29, 4:42 PM
Market Cap 40.91M
Revenue (ttm) 19.54M
Net Income (ttm) -3.62M
Shares Out 5.54M
EPS (ttm) -0.66
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 29
Last Price $7.33
Previous Close $7.39
Change ($) -0.06
Change (%) -0.81%
Day's Open 7.54
Day's Range 7.30 - 7.40
Day's Volume 1,144
52-Week Range 3.58 - 8.36

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

According to the GuruFocus All-in-One Screener, a Premium feature, as of June 28, the following companies are trading below their Peter Lynch fair values with wide margins of safety and have had positiv...

Other stocks mentioned: BDN, GPI, NNI, TPH
1 month ago - GuruFocus

MIAMI--(BUSINESS WIRE)---- $PMD--Montana Advisors issues open letter to Psychemedics CEO (Nasdaq: PMD): Dear Kubacki: It was a pleasure speaking with you two months ago via Zoom. I appreciate the time y...

1 month ago - Business Wire

ACTON, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair testing for drugs of abuse, today announced financial results for the first qua...

2 months ago - GlobeNewsWire

ACTON, Mass., March 23, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD), the world's largest provider of hair testing for drugs of abuse, today announced fourth quarter and full year fina...

4 months ago - GlobeNewsWire

ACTON, Mass., March 17, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) announced that Robyn C. Davis was unanimously elected to serve on the Board of Directors of Psychemedics Corporati...

4 months ago - GlobeNewsWire

ACTON, Mass., Jan. 26, 2021 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) announced that Andrew Limbek has joined the Company as Vice President, Controller.

6 months ago - GlobeNewsWire

ACTON, Mass., Dec. 17, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD) announced that Sarah Ashby has rejoined the company as Vice President, General Counsel.

7 months ago - GlobeNewsWire

ACTON, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced third quarter financial results for the period ended September 30, 2020.

8 months ago - GlobeNewsWire

ACTON, Mass., Aug. 12, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced second quarter financial results for the period ended June 30, 2020. 

11 months ago - GlobeNewsWire

ACTON, Mass., May 13, 2020 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today announced first quarter financial results for the period ended March 31, 2020. 

1 year ago - GlobeNewsWire

A New and Cost-Effective Tool to Detect and Deter Nicotine use A New and Cost-Effective Tool to Detect and Deter Nicotine use

1 year ago - GlobeNewsWire

The cannabis industry has grown in recent months and years, and many companies in the cannabis and health-related industries have been uplisted to reputable U.S. exchanges.

Other stocks mentioned: ARNA, CARA, CRBP, CRON, GNLN, GWPH, MBII ...
1 year ago - Investopedia

ACTON, Mass., Oct. 31, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ:PMD) today issued a response to a Massachusetts Supreme Judicial Court ruling in the case of Boston Police Department v...

1 year ago - GlobeNewsWire

ACTON, Mass., Sept. 19, 2019 (GLOBE NEWSWIRE) -- Psychemedics Corporation (Nasdaq:PMD) announced today that it has entered into a new distribution agreement in Brazil with Sansão Holding S.A. and with...

1 year ago - GlobeNewsWire

Psychemedics offers a novel way for testing drug abuse.

2 years ago - Seeking Alpha

Psychemedics provides drug testing via hair analysis.

2 years ago - Seeking Alpha

About PMD

Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States, Brazil, and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, PCP, amphetamines, opiates, synthetic cannabinoids, and benzodiazepines. Its testing results provide quantitative information that can indicate the approximate amount of drug ingested, as well as historical data that can show a pattern of individual ... [Read more...]

Industry
Diagnostics & Research
Founded
1986
Stock Exchange
NASDAQ
Ticker Symbol
PMD
Full Company Profile

Financial Performance

Financial Statements